119 Days
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
119 Daysالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
119 DaysReady to play
Ready to play
A British study has shown that the drug "semaglutide" can help obese patients who did not achieve satisfactory results from surgeries such as gastric sleeve and gastric bypass. The treatment demonstrated significant weight loss and a reduction in obesity-related health issues, along with improvements in blood sugar and cholesterol levels. The study involved 70 patients who had previously undergone bariatric surgeries, and it was found that 85% of them lost more than 10% of their body weight over 68 weeks. Most of the weight lost was from fat. The results underscore the potential of "semaglutide" as an alternative or complementary treatment after surgical failure, with further research ongoing to conduct larger-scale tests.
Notice: This Is an AI-Generated Summary
Comments (0)